[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f0bc_brhza1lvrL4-w6RVjO1Vzh10iuVYsN1XpQ1Ll8Y":8,"$fZTvv6zzVvHBLPhaK_Ki4qGVYG9LxA8jXA3nRKG2dpkA":17,"$fsVOZp3bMJTjHcctuiiPsWq_Jcx_leP26usXbzHZXbG4":21,"$fDMcKmTqhpvB9MdSU974cZJxIQwLl6ZVAnJNtqT2AYmA":98},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":16},200,"操作成功",{"pageNo":12,"pageSize":13,"result":14,"totalSize":15},1,10,[],0,true,{"code":9,"msg":10,"message":6,"data":18,"success":16},{"authors":19,"appraiseDimensionScoresVos":20},[],[],{"code":9,"msg":10,"message":6,"data":22,"success":16},{"id":23,"specialistId":24,"specialistAssistants":25,"profilePhoto":26,"specialistName":27,"roleType":15,"adept":28,"hospital":29,"department":30,"postsTitle":31,"materialTotal":15,"videoTotal":32,"isConcern":7,"title":33,"coverVertical":34,"coverAcross":35,"directionMarker":36,"description":37,"vid":38,"time":39,"mediaType":12,"views":40,"likes":15,"isThumbsUp":7,"isCollection":7,"collections":15,"createTime":41,"seoTitle":33,"seoKeywords":42,"seoDescription":43,"shelvesTime":44,"menus":45,"menuId":86,"type":36,"quality":96,"commentCount":15,"isComment":12,"deviceType":49,"url":97},36307,1068391,[],"https://ystcdn.venuertc.com/venue/app/50995/2026-09-22/104281ab-37bc-4c3a-b80b-2f6b9adf3382.png","王玲玲","擅长实体瘤和血液肿瘤治疗","沭阳仁慈医院","肿瘤科","副主任医师",3,"晚期胃癌靶向免疫方案选择依据，家属要知晓哪些细节","https://ystcdn.venuertc.com/venue/ai-cover/cover_vertical/d12a595c-0f49-45c6-972a-cd278830e183.png","https://ystcdn.venuertc.com/venue/ai-cover/cover_horizontal/d71dfc04-19dd-481a-b52c-df6feae0a95a.png",2,"\u003Ch2 id=\"material_title\">晚期胃癌靶向免疫方案选择依据，家属要知晓哪些细节\u003C/h2>\n\n\u003Cdiv class=\"custom_section\">\n  \u003Cdiv class=\"custom_subtitle\" style=\"background: linear-gradient(90deg, #f2f6fa 0%, #e6f3f9 100%);\">\n    晚期胃癌患者选方案时易被哪些误区困扰 💡\n  \u003C/div>\n  \u003Cp>\n    晚期胃癌靶向免疫方案选择依据，其实比不少人想象的复杂。有很多患者和家属觉得只要用最新药物或者盲目跟风，就能有“奇效”。但事实上，晚期胃癌的靶向免疫治疗，依据的是详细的病理报告、分子标志和身体状况，不是单凭网络推荐。咱们今天就好好聊聊晚期胃癌患者在方案选择上该关注哪些关键点。\n  \u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"custom_section\">\n  \u003Cdiv class=\"custom_subtitle\" style=\"background: linear-gradient(90deg, #f2f2ef 0%, #e5eddc 100%);\">\n    晚期胃癌靶向免疫方案选择靠哪些医学指标 🔎\n  \u003C/div>\n  \u003Cp>\n    晚期胃癌病情发展到一定阶段，靶向免疫方案的选择决策主要看三个核心指标。\u003Cbr>\n    1、\u003Cstrong>病理报告中的HER2状态\u003C/strong>：胃癌患者如果检测出HER2阳性，靶向药物的选择就有针对性，比如多数指南推荐的抗HER2药物。但HER2阴性的患者则需要考虑其他方案。\u003Cbr>\n    2、\u003Cstrong>PD-L1表达水平\u003C/strong>：这项检测能告诉医生免疫治疗的适用性。PD-L1阳性患者，部分免疫药物有较好反应，但不是所有人都适合，具体还要看身体耐受程度。\u003Cbr>\n    3、\u003Cstrong>分子标志和全身状况\u003C/strong>：有些患者还要检测MSI（微卫星不稳定性）、肿瘤负荷等指标，这些都影响靶向免疫药物可用性。身体情况，比如肝肾功能和体力状态，也很重要。\n    \u003Cbr>\u003Cspan style=\"color:#888;\">这些指标其实就像“路灯”，慢慢地在复杂的治疗路径上帮病人照亮方向，但实际选择还需结合多学科医生把关。\u003C/span>\n  \u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"custom_section\">\n  \u003Cdiv class=\"custom_subtitle\" style=\"background: linear-gradient(90deg, #f7faf6 0%, #dcebe1 100%);\">\n    晚期胃癌靶向免疫方案选择之前建议做哪些准备 🗂️\n  \u003C/div>\n  \u003Cp>\n    晚期胃癌患者和家属，建议务必做这几件事：\u003Cbr>\n    \u003Cstrong>建议怎么做：\u003C/strong>\u003Cbr>\n    - 先和主治医生详细沟通，了解相关病理分子结果，别着急选药。\n    - 定期监测肝肾功能、体力情况，及时反馈感受。\n    - 问清医生是否有多学科会诊的必要，对方案保持耐心等待与配合。\u003Cbr>\n    \u003Cstrong>不建议怎么做：\u003C/strong>\u003Cbr>\n    - 盲目相信网络“灵药”，忽略病理检测结果。\n    - 不做检查直接更换药物或停药。\n    - 跟风自购进口药品，不和医生商量。\n    \u003Cbr>晚期胃癌的靶向免疫治疗，适合自己的才可持续，千万不要因为心急而遗漏关键步。\n  \u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"custom_section\">\n  \u003Cdiv class=\"custom_subtitle\" style=\"background: linear-gradient(90deg, #f2f6fa 0%, #e6f3f9 100%);\">\n    晚期胃癌方案选择最不能忽视的检查和沟通 ☎️\n  \u003C/div>\n  \u003Cp>\n    晚期胃癌靶向免疫方案的选择，是一个动态过程。最重要的是定期复查相关分子指标，慢慢地根据病情调整药物。沟通和配合医生，别把希望全寄托在单一药物上。遇到不适症状，及时反馈，不要自行处理。\u003Cbr>\n    如果你或者身边人正经历晚期胃癌，记住以上这些细节，将会慢慢化解很多疑虑，也让治疗更有方向。\n  \u003C/p>\n\u003C/div>\n\n\u003Cstyle>\n.material_title {\n  font-size: 24px;\n  font-weight: bold;\n  color: #374151;\n  margin-bottom: 16px;\n  margin-top: 0px;\n  letter-spacing: 0.5px;\n}\n.custom_section {\n  margin-bottom: 28px;\n  border-radius: 12px;\n  padding: 20px 18px;\n  background-color: #fff;\n  box-shadow: 0px 2px 8px 0px rgba(234, 236, 241, 0.18);\n}\n.custom_subtitle {\n  font-size: 18px;\n  color: #1e293b;\n  font-weight: 500;\n  border-radius: 8px;\n  padding: 10px 16px;\n  margin-bottom: 14px;\n  background-repeat: no-repeat;\n  background-size: cover;\n  background-position: center;\n  display: flex;\n  align-items: center;\n}\n.custom_section p {\n  font-size: 16px;\n  color: #475569;\n  line-height: 1.7;\n  margin: 0;\n}\nstrong {\n  color: #045f90;\n}\n\u003C/style>","v0247cg10004db49naa7dldcfd3jhb8g",205,609,"2026-09-23 19:52:53","晚期胃癌, 靶向治疗, 免疫治疗, 病理报告, HER2","了解晚期胃癌靶向免疫方案选择的关键指标，以及患者及家属应该避免的误区，提升治疗效果。","2026-10-17 00:15:00",[46,67,85],{"menuId":47,"menuName":48,"parentId":15,"orderNum":49,"path":50,"component":51,"isFrame":52,"isCache":53,"menuType":54,"visible":12,"status":15,"createDept":6,"remark":55,"createTime":56,"children":57,"columnImage":58,"columnLogo":59,"uncheckedLogo":60,"checkedLogo":61,"isHot":12,"isHome":15,"forceLogin":15,"color":62,"seoTitle":63,"seoKeywords":64,"seoDescription":64,"contentNum":6,"promotionalPoster":65,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":66,"routerPath":50,"componentInfo":51},"1997925012023775234","热门频道",4,"column","/column/tcm_index.html","1","0","T","","2025-12-08 15:03:37",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:10:18/ef345cdc-bb06-4db5-b74d-6ecfafabe83e.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:10:21/81815950-9711-4b40-8543-421bd7701d0f.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:10:32/99452289-a401-4ab2-ae91-2a1a1f7442d1.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:10:29/f52b1198-7225-4f72-89f3-605e6a14f530.png","#42a5f6","sadf","asdf","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:10:25/cf4f002d-c534-4c28-b405-a2e504dc5188.png","Column",{"menuId":68,"menuName":69,"parentId":47,"orderNum":70,"path":71,"component":72,"isFrame":52,"isCache":53,"menuType":54,"visible":12,"status":15,"createDept":6,"remark":55,"createTime":73,"children":74,"columnImage":75,"columnLogo":76,"uncheckedLogo":77,"checkedLogo":78,"isHot":15,"isHome":15,"forceLogin":15,"color":79,"seoTitle":80,"seoKeywords":81,"seoDescription":82,"contentNum":6,"promotionalPoster":83,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":84,"routerPath":71,"componentInfo":72},"1989172310225670145","公益项目",6,"public","/column/public_index.html","2025-11-14 11:23:30",[],"https://ystcdn.venuertc.com/venue/undefined/2025-12-18-14:41:13/1b7a5e2b-9e7d-4769-851f-1c55c481fa82.png","https://ystcdn.venuertc.com/venue/undefined/2025-12-18-14:41:18/b79a0a5e-411c-4282-8eaf-86fcc7e492bf.png","https://ystcdn.venuertc.com/venue/undefined/2025-12-24-16:17:17/6f411ecf-82d8-4fb5-9371-fa7faba2cb8f.png","https://ystcdn.venuertc.com/venue/undefined/2025-12-24-16:17:16/93f832c4-2264-4094-88fd-6fd80c8d9369.png","#80cbc4","健康科普工公益行——携手共建健康未来","健康,科普,公益行,健康知识,公众健康,社会健康,健康活动,健康意识","健康科普工公益行活动,传播健康知识,提高公众健康意识,共同促进社会健康发展,关注您和家人的健康！","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:12:46/1f2ac83a-c564-4aeb-ad97-5b5c4f09bfa5.png","Public",{"menuId":86,"menuName":87,"parentId":68,"orderNum":70,"path":88,"component":89,"isFrame":52,"isCache":53,"menuType":54,"visible":12,"status":15,"createDept":6,"remark":55,"createTime":90,"children":91,"columnImage":92,"columnLogo":6,"uncheckedLogo":6,"checkedLogo":6,"isHot":15,"isHome":15,"forceLogin":15,"color":6,"seoTitle":87,"seoKeywords":93,"seoDescription":94,"contentNum":6,"promotionalPoster":6,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":95,"routerPath":88,"componentInfo":89},"2047224557296840705","“健康中国-医路相伴健康同行”肿瘤领域科普传播计划","publicTFPAPP","/column/public_publicTFPAPP","2026-04-23 16:02:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-04-23-15:59:55/812f101e-9b62-472f-b155-2cb356602a89.png","肿瘤科普、癌症科普、肿瘤防治、科学抗癌、健康中国科普、医路相伴健康同行","响应 \"健康中国 2030\" 战略，\"健康中国 - 医路相伴健康同行\" 肿瘤领域科普传播计划，联合权威医学专家，提供肿瘤预防、筛查、治疗、康复全周期科学科普内容，普及抗癌知识，破除健康误区，助力全民肿瘤防治素养提升。","PublicTFPAPP","癌症肿瘤","https://vod.haohuanjiao.com/huanjiao/specialistVideo/1068391/6a07ff6f-6b67-47f8-9a01-a5cb45335f6c.tmp?a=0&auth_key=1794818795-02e273ca30554156b3a71f0a914e4790-0-988bcef016218ba841d3a6790e14a21a&br=723&bt=723&cd=0%7C0%7C0&ch=0&cr=0&cs=0&dr=0&ds=3&eid=v0247cg10004db49naa7dldcfd3jhb8g&er=0&l=20261017064305E0D3B7F4C64223F50015&lr=&mime_type=video_mp4&net=0&pl=0&qs=13&rc=amVtZ2ZvOmQ8ZTczNGY3M0ApO2s2aWdnZHE3ZzMzajo1eWc1ZTBjYWFeazFhLS1kNC9zc2RfZ2FgaTReNl8xLS5gMS06Yw%3D%3D&vl=&vr=",{"code":9,"msg":97,"message":6,"data":6,"success":16}]